| Primary |
| Acute Coronary Syndrome |
28.4% |
| Stent Placement |
14.3% |
| Acute Myocardial Infarction |
11.6% |
| Coronary Artery Disease |
7.3% |
| Myocardial Infarction |
6.8% |
| Hypertension |
6.5% |
| Diabetes Mellitus |
3.0% |
| Percutaneous Coronary Intervention |
2.5% |
| Coronary Arterial Stent Insertion |
2.3% |
| Thrombosis Prophylaxis |
2.2% |
| Angina Pectoris |
2.0% |
| Cardiac Disorder |
1.9% |
| Anticoagulant Therapy |
1.7% |
| Cardiovascular Event Prophylaxis |
1.7% |
| Antiplatelet Therapy |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Blood Cholesterol Abnormal |
1.3% |
| Angina Unstable |
1.3% |
| Blood Pressure Abnormal |
1.1% |
| Ischaemic Heart Disease Prophylaxis |
1.1% |
|
| Dyspnoea |
18.0% |
| Thrombosis In Device |
16.4% |
| Myocardial Infarction |
10.6% |
| Death |
7.9% |
| Gastrointestinal Haemorrhage |
6.6% |
| Rash |
6.6% |
| Haemorrhage |
6.0% |
| Malaise |
3.1% |
| Off Label Use |
2.9% |
| Intentional Drug Misuse |
2.7% |
| Thrombosis |
2.7% |
| Cerebrovascular Accident |
2.3% |
| Epistaxis |
2.0% |
| Thrombocytopenia |
2.0% |
| Chest Pain |
1.9% |
| Syncope |
1.9% |
| Bradycardia |
1.7% |
| Acute Myocardial Infarction |
1.6% |
| Haemorrhage Intracranial |
1.6% |
| Pain |
1.6% |
|
| Secondary |
| Acute Coronary Syndrome |
14.9% |
| Hypertension |
11.8% |
| Stent Placement |
10.7% |
| Coronary Artery Disease |
10.0% |
| Myocardial Infarction |
7.3% |
| Acute Myocardial Infarction |
7.1% |
| Blood Cholesterol Increased |
5.9% |
| Diabetes Mellitus |
3.9% |
| Cardiac Disorder |
3.7% |
| Anticoagulant Therapy |
3.6% |
| Blood Cholesterol Abnormal |
3.6% |
| Angina Pectoris |
2.4% |
| Angina Unstable |
2.3% |
| Carotid Artery Stent Insertion |
2.1% |
| Coronary Artery Occlusion |
2.0% |
| Coronary Arterial Stent Insertion |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Gastric Disorder |
1.8% |
| Blood Pressure Abnormal |
1.6% |
| Antiplatelet Therapy |
1.5% |
|
| Off Label Use |
15.8% |
| Dyspnoea |
13.3% |
| Myocardial Infarction |
10.2% |
| Thrombosis In Device |
9.9% |
| Rash |
6.2% |
| Weight Decreased |
4.8% |
| Gastrointestinal Haemorrhage |
4.2% |
| Venous Occlusion |
4.2% |
| Wheezing |
3.7% |
| Pain In Extremity |
3.1% |
| Coronary Artery Occlusion |
2.8% |
| Haematoma |
2.8% |
| Intentional Drug Misuse |
2.5% |
| Mallory-weiss Syndrome |
2.5% |
| Syncope |
2.5% |
| Thrombosis |
2.5% |
| Gastric Ulcer Haemorrhage |
2.3% |
| Squamous Cell Carcinoma |
2.3% |
| Weight Increased |
2.3% |
| Abdominal Pain |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.0% |
| Hypertension |
11.9% |
| Cardiac Disorder |
6.7% |
| Anticoagulant Therapy |
4.4% |
| Blood Cholesterol Increased |
4.4% |
| Rheumatoid Arthritis |
3.7% |
| Blood Triglycerides Increased |
3.0% |
| Diabetes Mellitus |
3.0% |
| Percutaneous Coronary Intervention |
3.0% |
| Type 2 Diabetes Mellitus |
3.0% |
| Cardiovascular Event Prophylaxis |
2.2% |
| Spinal Column Stenosis |
2.2% |
| Stent Placement |
2.2% |
| Type 1 Diabetes Mellitus |
2.2% |
| Depression |
1.5% |
| Device Therapy |
1.5% |
| Non-hodgkin's Lymphoma |
1.5% |
| Osteoporosis |
1.5% |
| Psoriasis |
1.5% |
| Acromegaly |
0.7% |
|
| Myocardial Infarction |
17.1% |
| Syncope |
8.6% |
| Weight Decreased |
8.6% |
| Coronary Artery Occlusion |
5.7% |
| Feeling Abnormal |
5.7% |
| Infection |
5.7% |
| Loss Of Consciousness |
5.7% |
| Platelet Count Decreased |
5.7% |
| Ventricular Fibrillation |
5.7% |
| Acute Myocardial Infarction |
2.9% |
| Atrioventricular Block |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Chest Pain |
2.9% |
| Confusional State |
2.9% |
| Constipation |
2.9% |
| Dyspnoea Exertional |
2.9% |
| Epistaxis |
2.9% |
| Femur Fracture |
2.9% |
| Headache |
2.9% |
| Hypertension |
2.9% |
|
| Interacting |
| Acute Coronary Syndrome |
21.4% |
| Coronary Angioplasty |
21.4% |
| Hiv Infection |
21.4% |
| Stent Placement |
9.5% |
| Acute Myocardial Infarction |
7.1% |
| Oedema |
4.8% |
| Pain |
4.8% |
| Product Used For Unknown Indication |
4.8% |
| Thrombosis Prophylaxis |
4.8% |
|
| Drug Interaction |
27.3% |
| Retinal Detachment |
27.3% |
| Epidermal Growth Factor Receptor Decreased |
9.1% |
| Haemoglobin Decreased |
9.1% |
| Hypovolaemic Shock |
9.1% |
| Oedema |
9.1% |
| Pneumonia |
9.1% |
|
